4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000899243-22-031059
Options or other derivatives
- Chief Medical Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nichols William Garrett Chief Medical Officer | 2022-09-12 | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…